Jeff Barrett appointed CTTV's founding director
This article was originally published in Scrip
Executive Summary
Dr Jeffrey Barrett has been appointed the founding director of the Centre for Therapeutic Target Validation (CTTV), a public-private partnership between GlaxoSmithKline, the European Bioinformatics Institute (EMBL-EBI) and the Wellcome Trust Sanger Institute (scripintelligence.com, 27 March 2014). Dr Barrett has been involved in the CTTV since its inception in 2014 and will begin his new role on 1 May 2015.